10-Methoxyyangonin



Compound IDCDAMM00745
Common name10-Methoxyyangonin
IUPAC name6-[2-(2,4-dimethoxyphenyl)ethenyl]-4-methoxypyran-2-one
Molecular formulaC16H16O5

Experimental data

Retention time7.4
Adduct[M+Na]+
Actual mz311.086
Theoretical mz311.089
Error9.38
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.9755

Identifiers and class information

Inchi keyAKMMSYGGUVGJEE-FNORWQNLSA-N
SmilesO=C1OC(C=CC2=CC=C(OC)C=C2OC)=CC(OC)=C1
SuperclassPhenylpropanoids and polyketides
ClassKavalactones

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)6
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)0
Molecular weight (mol_MW)288.299
Computed dipole moment(dipole)7.288
Total solvent accessible surface area (SASA)566.467
Hydrophobic component of SASA (FOSA)294.303
Hydrophilic component of SASA (FISA)71.131
Pie component of the SASA (PISA)201.034
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)957.12
Number of hydrogen bond donors (donorHB)0
Number of hydrogen bond acceptors (accptHB)4.75
Free energy of solvation of dipole (dip^2/V)0.0554951
Index of cohesive interaction in solids (ACxDN^.5/SA)0
Globularity descriptor (glob)0.829153
Predicted polarizability in cubic angstroms (QPpolrz)30.217
Predicted hexadecane/gas partition coefficient (QPlogPC16)8.941
Predicted octanol/gas partition coefficient (QPlogPoct)12.624
Predicted water/gas partition coefficient (QPlogPw)6.289
Predicted octanol/water partition coefficient (QPlogPo/w)2.969
Predicted aqueous solubility (QPlogS)-3.488
Conformation-independent predicted aqueous solubility (CIQPlogS)-3.711
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.255
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)2095.89
Predicted brain/blood partition coefficient (QPlogBB)-0.488
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)1100.81
Predicted skin permeability, log Kp (QPlogKp)-1.546
PM3 calculated ionization potential (IP(ev))8.644
PM3 calculated electron affinity (EA(eV))0.974
Number of likely metabolic reactions (#metab)3
Prediction of binding to human serum albumin (QPlogKhsa)-0.129
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)62.095
Number of nitrogen and oxygen atoms (#NandO)5
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P05067APPBeta amyloid A4 proteinT87024SEA
P16083NQO2Quinone reductase 2T75498SEA
P19838NFKB1Nuclear factor NF-kappa-B p105 subunitT83145SEA
P43166CA7Carbonic anhydrase VIIT37541SEA
P27338MAOBMonoamine oxidase BT83011SEA
P29350PTPN6Protein-tyrosine phosphatase 1CT98264SEA
P08183ABCB1P-glycoprotein 1T25258SEA
P11474ESRRAEstrogen-related receptor alphaT72841SEA
P19838NFKB1Nuclear factor NF-kappa-B p105 subunitT83145SEA
Q9UNQ0ABCG2ATP-binding cassette sub-family G member 2T56556SEA
Q16678CYP1B1Cytochrome P450 1B1T92521SEA
P10636MAPTMicrotubule-associated protein tauT45593SEA
P19438TNFRSF1ATumor necrosis factor receptor R1T86552SEA
Q16236NFE2L2Nuclear factor erythroid 2-related factor 2T88505SEA
Q9H4B7TUBB1Tubulin beta-1 chainT84397SEA
O15427SLC16A3Monocarboxylate transporter 4T31788SEA
Q9Y6Q9NCOA3Nuclear receptor coactivator 3T26774SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T87024DI0025Alzheimer disease[ICD-11: 8A20]P05067APP
T87024DI0122Diagnostic imaging[ICD-11: N.A.]P05067APP
T75498DI0214Insomnia[ICD-11: 7A00-7A0Z]P16083NQO2
T83145DI0218Irritable bowel syndrome[ICD-11: DD91]P19838NFKB1
T83145DI0366Rheumatoid arthritis[ICD-11: FA20]P19838NFKB1
T83011DI0115Dementia[ICD-11: 6D80-6D8Z]P27338MAOB
T83011DI0117Depression[ICD-11: 6A70-6A7Z]P27338MAOB
T83011DI0190Hypertension[ICD-11: BA00-BA04]P27338MAOB
T83011DI0243Malaria[ICD-11: 1F40-1F45]P27338MAOB
T83011DI0264Migraine[ICD-11: 8A80]P27338MAOB
T83011DI0331Parkinsonism[ICD-11: 8A00]P27338MAOB
T25258DI0238Lung cancer[ICD-11: 2C25]P08183ABCB1
T72841DI0366Rheumatoid arthritis[ICD-11: FA20]P11474ESRRA
T83145DI0218Irritable bowel syndrome[ICD-11: DD91]P19838NFKB1
T83145DI0366Rheumatoid arthritis[ICD-11: FA20]P19838NFKB1
T56556DI0218Irritable bowel syndrome[ICD-11: DD91]Q9UNQ0ABCG2
T56556DI0366Rheumatoid arthritis[ICD-11: FA20]Q9UNQ0ABCG2
T45593DI0012Acute myeloid leukaemia[ICD-11: 2A60]P10636MAPT
T45593DI0025Alzheimer disease[ICD-11: 8A20]P10636MAPT
T45593DI0265Mild neurocognitive disorder[ICD-11: 6D71]P10636MAPT
T86552DI0060Brain cancer[ICD-11: 2A00]P19438TNFRSF1A
T86552DI0321Ovarian cancer[ICD-11: 2C73]P19438TNFRSF1A
T88505DI0038Ataxic disorder[ICD-11: 8A03]Q16236NFE2L2
T84397DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q9H4B7TUBB1

Copyright © 2025